Modern Research Center for Traditional Chinese Medicine of Shanxi University, Taiyuan 030006, PR China.
Behav Brain Res. 2013 Mar 15;241:86-91. doi: 10.1016/j.bbr.2012.11.036. Epub 2012 Dec 3.
To investigate and compare the metabonomic profiles of three stress-based models of depression, the effects of acute and chronic stress on the production of systemic endogenous metabolites were investigated. Such metabonomic analysis may provide researchers a new way of selecting appropriate animal models for the study of depression and antidepressants. Rats were subjected to one of three stress-based models: CUMS, FST-1d, or FST-14d. Endogenous metabolites excreted in plasma were analyzed using NMR in conjunction with multivariate and statistical techniques. The metabonomic study indicated that the concentration of different plasma metabolites could be used to differentiate among depression models: TMA, aspartic acid, glutamate, AcAc, NAc, alanine, lactate, Leu/Ile, lipids increased and proline, β-HB, valine decreased in the CUMS model; TMA decreased in the FST-1d model; α-glucose, β-glucose, β-HB, valine and lipids increased in the FST-14d model. The results suggested that metabonomics is a potentially appropriate method for evaluating depression models. According to the metabonomics study, CUMS model was more suitable and sensitive than the acute FST-1d model and predictable FST-14d model. The CUMS model was more appropriate for investigating both the efficacy of antidepressants and their mechanisms of action, while the FST-14d model should only be used for evaluating the efficacy of treatment.
为了研究和比较三种基于应激的抑郁模型的代谢组学特征,我们考察了急性和慢性应激对系统内源性代谢产物产生的影响。这种代谢组学分析可能为研究人员提供一种选择合适的动物模型来研究抑郁症和抗抑郁药物的新方法。大鼠分别接受三种基于应激的模型之一的处理:CUMS、FST-1d 或 FST-14d。使用 NMR 结合多元统计技术分析了血浆中内源性代谢产物。代谢组学研究表明,不同血浆代谢物的浓度可以用于区分抑郁模型:CUMS 模型中 TMA、天冬氨酸、谷氨酸、AcAc、NAc、丙氨酸、乳酸、亮氨酸/异亮氨酸、脂质增加,脯氨酸、β-HB、缬氨酸减少;FST-1d 模型中 TMA 减少;FST-14d 模型中α-葡萄糖、β-葡萄糖、β-HB、缬氨酸和脂质增加。结果表明,代谢组学是评估抑郁模型的一种潜在合适方法。根据代谢组学研究,CUMS 模型比急性 FST-1d 模型和可预测的 FST-14d 模型更合适和敏感。CUMS 模型更适合研究抗抑郁药物的疗效及其作用机制,而 FST-14d 模型仅应用于评估治疗效果。